EASL Studio Policy Dialogues Ep5 - The lives of liver patients: Prejudice and stigma

EASL Policy Dialogues S2E5 - Rare but not forgotten – The challenges of living with PBCПодробнее

EASL Studio Policy Dialogues Ep4 - Fatty Liver Disease: The Approaching Tsunami in NCDsПодробнее

EASL Studio Policy Dialogues - Episode 2 - The liver, alcohol, and politicsПодробнее

EASL Studio Policy Dialogues Episode 3 - Liver Cancer: The Risk of IgnoranceПодробнее

EASL Policy Dialogue Episode 2 - World Liver Day - 19 April 2023Подробнее

EASL Studio S5E5 - JHEP Live: The new nomenclature for SLDПодробнее

EASL Studio S7E5 - Why does WHO engagement with Steatotic Liver Disease matter?Подробнее

EASL Studio Policy Dialogues - Episode 1 - Drug use, viral hepatitis, and EuropeПодробнее

EASL Policy Dialogues - Enhancing Treatment Adherence & Quality of life in Rare Liver DiseaseПодробнее

EASL Studio - S5E13 Promo - Basics in decision-making for liver cancer treatmentПодробнее

EASL Studio Special Episode “Promoting Liver Health: an urgent call for action at WHO”Подробнее

EASL Policy Dialogues S2E6 - Diagnosing Steatotic Liver Disease – Challenges and opportunitiesПодробнее

EASL Policy Dialogues S2E8 - The political battle to reduce harms caused by alcoholПодробнее

EASL Studio S4E18 - Liver nurses in Europe: are there enough and can they do more?Подробнее

EASL Studio S5 Special Episode - Highlights from the EASL SLD Summit 2023Подробнее

EASL Policy Dialogues S3E1 - Rarity and parity – Addressing inequities in rare liver diseaseПодробнее

EASL Studio - S6E5 Promo - JHEP Live: Compensated advanced chronic liver disease (cACLD)Подробнее

EASL Policy Dialogues S2E9 - Preventing liver disease with policy measures: The Hepahealth II studyПодробнее